Cargando…

α-synuclein strains that cause distinct pathologies differentially inhibit proteasome

Abnormal α-synuclein aggregation has been implicated in several diseases and is known to spread in a prion-like manner. There is a relationship between protein aggregate structure (strain) and clinical phenotype in prion diseases, however, whether differences in the strains of α-synuclein aggregates...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Genjiro, Imura, Sei, Hosokawa, Masato, Katsumata, Ryu, Nonaka, Takashi, Hisanaga, Shin-Ichi, Saeki, Yasushi, Hasegawa, Masato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406352/
https://www.ncbi.nlm.nih.gov/pubmed/32697196
http://dx.doi.org/10.7554/eLife.56825
_version_ 1783567401257795584
author Suzuki, Genjiro
Imura, Sei
Hosokawa, Masato
Katsumata, Ryu
Nonaka, Takashi
Hisanaga, Shin-Ichi
Saeki, Yasushi
Hasegawa, Masato
author_facet Suzuki, Genjiro
Imura, Sei
Hosokawa, Masato
Katsumata, Ryu
Nonaka, Takashi
Hisanaga, Shin-Ichi
Saeki, Yasushi
Hasegawa, Masato
author_sort Suzuki, Genjiro
collection PubMed
description Abnormal α-synuclein aggregation has been implicated in several diseases and is known to spread in a prion-like manner. There is a relationship between protein aggregate structure (strain) and clinical phenotype in prion diseases, however, whether differences in the strains of α-synuclein aggregates account for the different pathologies remained unclear. Here, we generated two types of α-synuclein fibrils from identical monomer and investigated their seeding and propagation ability in mice and primary-cultured neurons. One α-synuclein fibril induced marked accumulation of phosphorylated α-synuclein and ubiquitinated protein aggregates, while the other did not, indicating the formation of α-synuclein two strains. Notably, the former α-synuclein strain inhibited proteasome activity and co-precipitated with 26S proteasome complex. Further examination indicated that structural differences in the C-terminal region of α-synuclein strains lead to different effects on proteasome activity. These results provide a possible molecular mechanism to account for the different pathologies induced by different α-synuclein strains.
format Online
Article
Text
id pubmed-7406352
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher eLife Sciences Publications, Ltd
record_format MEDLINE/PubMed
spelling pubmed-74063522020-08-06 α-synuclein strains that cause distinct pathologies differentially inhibit proteasome Suzuki, Genjiro Imura, Sei Hosokawa, Masato Katsumata, Ryu Nonaka, Takashi Hisanaga, Shin-Ichi Saeki, Yasushi Hasegawa, Masato eLife Neuroscience Abnormal α-synuclein aggregation has been implicated in several diseases and is known to spread in a prion-like manner. There is a relationship between protein aggregate structure (strain) and clinical phenotype in prion diseases, however, whether differences in the strains of α-synuclein aggregates account for the different pathologies remained unclear. Here, we generated two types of α-synuclein fibrils from identical monomer and investigated their seeding and propagation ability in mice and primary-cultured neurons. One α-synuclein fibril induced marked accumulation of phosphorylated α-synuclein and ubiquitinated protein aggregates, while the other did not, indicating the formation of α-synuclein two strains. Notably, the former α-synuclein strain inhibited proteasome activity and co-precipitated with 26S proteasome complex. Further examination indicated that structural differences in the C-terminal region of α-synuclein strains lead to different effects on proteasome activity. These results provide a possible molecular mechanism to account for the different pathologies induced by different α-synuclein strains. eLife Sciences Publications, Ltd 2020-07-22 /pmc/articles/PMC7406352/ /pubmed/32697196 http://dx.doi.org/10.7554/eLife.56825 Text en © 2020, Suzuki et al http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Neuroscience
Suzuki, Genjiro
Imura, Sei
Hosokawa, Masato
Katsumata, Ryu
Nonaka, Takashi
Hisanaga, Shin-Ichi
Saeki, Yasushi
Hasegawa, Masato
α-synuclein strains that cause distinct pathologies differentially inhibit proteasome
title α-synuclein strains that cause distinct pathologies differentially inhibit proteasome
title_full α-synuclein strains that cause distinct pathologies differentially inhibit proteasome
title_fullStr α-synuclein strains that cause distinct pathologies differentially inhibit proteasome
title_full_unstemmed α-synuclein strains that cause distinct pathologies differentially inhibit proteasome
title_short α-synuclein strains that cause distinct pathologies differentially inhibit proteasome
title_sort α-synuclein strains that cause distinct pathologies differentially inhibit proteasome
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406352/
https://www.ncbi.nlm.nih.gov/pubmed/32697196
http://dx.doi.org/10.7554/eLife.56825
work_keys_str_mv AT suzukigenjiro asynucleinstrainsthatcausedistinctpathologiesdifferentiallyinhibitproteasome
AT imurasei asynucleinstrainsthatcausedistinctpathologiesdifferentiallyinhibitproteasome
AT hosokawamasato asynucleinstrainsthatcausedistinctpathologiesdifferentiallyinhibitproteasome
AT katsumataryu asynucleinstrainsthatcausedistinctpathologiesdifferentiallyinhibitproteasome
AT nonakatakashi asynucleinstrainsthatcausedistinctpathologiesdifferentiallyinhibitproteasome
AT hisanagashinichi asynucleinstrainsthatcausedistinctpathologiesdifferentiallyinhibitproteasome
AT saekiyasushi asynucleinstrainsthatcausedistinctpathologiesdifferentiallyinhibitproteasome
AT hasegawamasato asynucleinstrainsthatcausedistinctpathologiesdifferentiallyinhibitproteasome